HB1091 is the Arkansas Department of Health appropriation act for fiscal year 2025-2026. It sets the agency’s authorized staffing levels and operating budgets across the Department of Health’s shared services, general operations, trauma system, and several dedicated programs and funds. The bill appropriates funds for salaries, extra help, matching costs, operating expenses, grants and aid, and specific programmatic uses such as the Kidney Disease Program, Breast Care Program, infectious disease control, WIC food instruments, emergency medical services, nuclear planning grants, interpreter services for deaf and hard of hearing individuals, and the Full Independent Practice Credentialing Committee.
The bill also includes special language governing how the department may use and transfer funds. It authorizes carry-forward of certain trauma system funds, allows up to $3.7 million in carry-forward funds to support emergency management integration and long-acting reversible contraceptives through local health units, requires a minimum annual allocation of $4.755 million for the Breast Care Program, and permits shared-services fund transfers within the department. The act contains an emergency clause so it takes effect on July 1, 2025, and applies only for the 2025-2026 fiscal year.
In practical terms, HB1091 maintains the legal authority for the Department of Health to spend state and other designated funds and to employ up to the listed number of staff in each classification. It does not create a new regulatory program, but it does shape how existing public health functions are financed and administered, including trauma response, disease control, maternal and child nutrition, local health unit support, and health facility oversight. It also directs spending from several special revenue and cash funds, which affects how those funds may be used under state fiscal law.
The overall sentiment appears strongly supportive and routine, consistent with a budget measure for an essential agency. The bill passed the House 93-1 and the Senate 35-0, indicating broad bipartisan approval and little visible opposition in the recorded votes. No committee transcript was provided, and there is no indication of sustained controversy in the available record.
The main points of potential contention are not reflected in the vote totals but are embedded in the bill’s special language and program earmarks. The Breast Care Program minimum funding, the use of carry-forward funds for contraceptive services, and the allocation of funds for trauma-system integration could draw policy interest from legislators focused on public health priorities, reproductive health, or budget flexibility. Even so, the near-unanimous votes suggest these issues did not generate significant opposition during passage.
HB1091 continues and funds the Department of Health’s operations for FY2025-2026 by appropriating more than $330 million for general operations, plus additional appropriations for the trauma system, health building and local health grants, nuclear planning, EMS, WIC food instruments, interpreter services, and independent practice credentialing. It establishes or renews maximum employee counts across numerous classifications and authorizes temporary staffing where needed. The act also includes special fiscal directives that affect how the department may transfer, carry forward, and dedicate funds, including specific requirements for the Breast Care Program and trauma-related carry-forward funds.
The bill appears to have been viewed as a standard and necessary appropriations measure for a core state agency. The recorded floor votes were overwhelmingly favorable in both chambers, with only one dissenting vote in the House and unanimous approval in the Senate. That voting pattern suggests broad agreement on funding the Department of Health’s operations and related public health programs, with no major public dispute reflected in the available materials.
No formal committee debate or transcript is available, so specific objections are not documented in the record provided. The most likely areas of policy sensitivity are the bill’s earmarked spending and special language, especially the minimum funding requirement for the Breast Care Program, the authorization to use carry-forward funds for emergency management integration and long-acting reversible contraceptives, and the department’s authority to move funds among programs. These provisions could attract scrutiny from members concerned about reproductive health policy, budget flexibility, or the use of dedicated public health funds, but the vote totals indicate little organized opposition.